CTSU ECOG E1609
Title:
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma
Available at:
Cox Health Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Central Cares Cancer Center, Bolivar, MO
Skaggs Cancer Center, Branson, MO
Phelps County Regional Medical Center, Rolla, MO
Mercy Clinic, Rolla, MO
For more information about this clinical trial, click
here.